Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metal complexes against breast cancer stem cells
Yingsi Li, Boxin Liu, Hongdong Shi, et al.
Dalton Transactions (2021) Vol. 50, Iss. 41, pp. 14498-14512
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Construction of homo and heteronuclear Ru(II), Ir(III) and Re(I) complexes for target specific cancer therapy
Sudhindra Pete, Nilmadhab Roy, Binoy Kar, et al.
Coordination Chemistry Reviews (2022) Vol. 460, pp. 214462-214462
Closed Access | Times Cited: 39
Beyond cisplatin: New frontiers in metallodrugs for hard-to-treat triple negative breast cancer
Muhammad Nafees, Muhammad Hanif, Piaoping Yang
Coordination Chemistry Reviews (2023) Vol. 499, pp. 215507-215507
Closed Access | Times Cited: 26
Reactive Oxygen Species Inducing Triazolylpyridine-Based Ru(II)/Ir(III) Complexes for Therapeutically Enhanced Triple-Negative Breast Cancer Treatment
Utpal Das, Shanooja Shanavas, Meena Jayaprakash, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Novel Au Carbene Complexes as Promising Multi-Target Agents in Breast Cancer Treatment
Jessica Ceramella, Annaluisa Mariconda, Marco Sirignano, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 507-507
Open Access | Times Cited: 28
Structural characterization, DNA binding study, antioxidant potential and antitumor activity of diorganotin(IV) complexes against human breast cancer cell line MDA-MB-231
Shaista Ramzan, Shaukat Shujah, Katherine B. Holt, et al.
Journal of Organometallic Chemistry (2023) Vol. 990, pp. 122671-122671
Open Access | Times Cited: 22
Synthesis and anticancer mechanisms of zinc(ii)-8-hydroxyquinoline complexes with 1,10-phenanthroline ancillary ligands
Ling-Qi Du, Tianyu Zhang, Xiaomei Huang, et al.
Dalton Transactions (2023) Vol. 52, Iss. 15, pp. 4737-4751
Closed Access | Times Cited: 19
Arene–Arene Coupled Disulfamethazines (or Sulfadiazine)-Phenanthroline-Metal(II) Complexes were Synthesized by In Situ Reactions and Inhibited the Growth and Development of Triple-Negative Breast Cancer through the Synergistic Effect of Antiangiogenesis, Anti-Inflammation, Pro-Apoptosis, and Cuproptosis
Bing-Bing Xu, Nan Jin, J. Q. Liu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7088-7111
Closed Access | Times Cited: 7
Platinum(II) 5-substituted-8-hydroxyquinoline coordination compounds induces mitophagy-mediated apoptosis in A549/DDP cancer cells
Yan Yang, Ling-Qi Du, Yan Huang, et al.
Journal of Inorganic Biochemistry (2023) Vol. 241, pp. 112152-112152
Closed Access | Times Cited: 13
Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes
Aleksandr Kazimir, Benedikt Schwarze, Peter Lönnecke, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 682-682
Open Access | Times Cited: 13
The anti-breast cancer stem cell properties of gold(i)-non-steroidal anti-inflammatory drug complexes
Alice Johnson, Chibuzor Olelewe, Jong Hyun Kim, et al.
Chemical Science (2022) Vol. 14, Iss. 3, pp. 557-565
Open Access | Times Cited: 21
Research Progress on Bioactive Metal Complexes against ER-Positive Advanced Breast Cancer
Zhenlin Liang, Lijuan Liu, Yanyu Zhou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2235-2256
Closed Access | Times Cited: 12
G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2′-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells
Nilmadhab Roy, Shanooja Shanavas, Binoy Kar, et al.
ACS Omega (2023) Vol. 8, Iss. 13, pp. 12283-12297
Open Access | Times Cited: 12
Role of organometallic complexes in targeted therapies of different diseases: Infectious diseases, Cancer and Neurodegenerative Diseases
Nitin Verma, Tanmay Anand, Chandra Kant Singh, et al.
Journal of Organometallic Chemistry (2024), pp. 123389-123389
Closed Access | Times Cited: 4
Evaluation of an isatin-derived ligand and its metal complexes as potential anticancer agents in breast adenocarcinoma cells
Riyam N. Khalaf, Amal A. Hassan, Z. A. El‐Shafiey, et al.
Chemical Papers (2025)
Closed Access
Anti-Cancer Stem Cell Properties of Square Planar Copper(II) Complexes with Vanillin Schiff Base Ligands
Yihan Wang, Kuldip Singh, Chunxin Lu, et al.
Molecules (2025) Vol. 30, Iss. 7, pp. 1636-1636
Open Access
N‐Heterocyclic Carbene (NHC) Silver Complexes as Versatile Chemotherapeutic Agents Targeting Human Topoisomerases and Actin
Annaluisa Mariconda, Domenico Iacopetta, Marco Sirignano, et al.
ChemMedChem (2022) Vol. 17, Iss. 18
Open Access | Times Cited: 18
Reactive Oxygen Species Production Is Responsible for Antineoplastic Activity of Osmium, Ruthenium, Iridium and Rhodium Half-Sandwich Type Complexes with Bidentate Glycosyl Heterocyclic Ligands in Various Cancer Cell Models
István Kacsir, Adrienn Sipos, Attila Bényei, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 813-813
Open Access | Times Cited: 17
Half sandwich-type osmium, ruthenium, iridium and rhodium complexes with bidentate glycosyl heterocyclic ligands induce cytostasis in platinum-resistant ovarian cancer cells and bacteriostasis in Gram-positive multiresistant bacteria
István Kacsir, Adrienn Sipos, Tímea Kiss, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 10
Targeting chemotherapy-resistant tumour sub-populations using inorganic chemistry: Anti-cancer stem cell metal complexes
Joshua Northcote‐Smith, Kogularamanan Suntharalingam
Current Opinion in Chemical Biology (2022) Vol. 72, pp. 102237-102237
Open Access | Times Cited: 16
A review on DNA/BSA binding and cytotoxic properties of multinuclear Schiff’s base complexes
Deepa Krishnan, Angappan Sheela
Results in Chemistry (2022) Vol. 5, pp. 100732-100732
Open Access | Times Cited: 15
Benzimidazole-Based NHC Metal Complexes as Anticancer Drug Candidates: Gold(I) vs. Platinum(II)
Paul Kapitza, Patricia Grabher, Amelie Scherfler, et al.
Inorganics (2023) Vol. 11, Iss. 7, pp. 293-293
Open Access | Times Cited: 8
Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms
Lydia W. Njenga, Simon N. Mbugua, Ruth A. Odhiambo, et al.
Dalton Transactions (2023) Vol. 52, Iss. 18, pp. 5823-5847
Closed Access | Times Cited: 7
Aroylhydrazone Diorganotin Complexes Causes DNA Damage and Apoptotic Cell Death: From Chemical Synthesis to Biochemical Effects
Wujiu Jiang, Yu‐Xing Tan, Yiyuan Peng
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13525-13525
Open Access | Times Cited: 17
The strongin vitroandvivocytotoxicity of three new cobalt(ii) complexes with 8-methoxyquinoline
Yufeng Wang, Ji‐Xia Tang, Zai-Yong Mo, et al.
Dalton Transactions (2022) Vol. 51, Iss. 22, pp. 8840-8847
Closed Access | Times Cited: 11
Novel glycosylation zinc(II)–cryptolepine complexes perturb mitophagy pathways and trigger cancer cell apoptosis and autophagy in SK-OV-3/DDP cells
Zhen Zhou, Ling-Qi Du, Xiaomei Huang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114743-114743
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top